METHOD OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

This invention provides a pharmaceutical composition for arresting the development, or retarding the progression of SLE in a mammal which comprises rapamycin prepared by a process known $i(per se) and if desired a pharmaceutically acceptable carrier, diluent or excipient; said composition being adap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ADAMS, LAUREL, MOORE, WARNER, LINDA, MARIE
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPIRITS SUGARS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention provides a pharmaceutical composition for arresting the development, or retarding the progression of SLE in a mammal which comprises rapamycin prepared by a process known $i(per se) and if desired a pharmaceutically acceptable carrier, diluent or excipient; said composition being adapted for administration orally, parenterally, intranasally, intrabronchially, or rectally. L'invention décrit une composition pharmaceutique servant à arrêter le développement, ou retarder la progression du lupus erythémateux systémique chez les mammifères et comprenant de la rapamycine préparée au moyen d'un procédé connu et, si nécessaire, un agent porteur, un diluant ou un excipient acceptables pharmaceutiquement. Ladite composition est conçue pour être administrée par voie orale, parentérale, intranasale, intrabronchique ou rectale.